Pharmaceuticals: Major
Swiss companies operating in the same pharmaceuticals: major industry
The list below has Swiss companies that operate under the same industry, pharmaceuticals: major. The list helps track their performance, income statement, and more. Sorted by any necessary metric, it can show the most expensive stocks of the industry such as REGENERON PHARMACEUTICALS INC or those with the best price dynamics like EMERGENT BIOSOLUTI, thus assisting in designing strategies of any focus.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND CO | 702.213 B CHF | 719.857 CHF | −2.84% | 22 | 0.82 | 119.50 | 6.02 CHF | +6.31% | 0.58% | Health Technology | Buy |
| LLYLILLY ELI | 702.213 B CHF | 725 CHF | −0.68% | 25 | 1.32 | 120.36 | 6.02 CHF | +6.31% | 0.58% | Health Technology | Buy |
 NOVNOVO NORDISK A/S | 542.403 B CHF | 121.553 CHF | −0.68% | 263 | 0.45 | 46.90 | 2.59 CHF | +44.47% | 1.02% | Health Technology | Buy |
 JNJJOHNSON & JOHNSON | 323.67 B CHF | 132.318 CHF | −2.68% | 171 | 7.18 | 21.13 | 6.26 CHF | +43.07% | 3.24% | Health Technology | Buy |
 6MKMERCK & CO INC | 300.119 B CHF | 114.900 CHF | −4.28% | 100 | 2.87 | 141.79 | 0.81 CHF | −82.71% | 2.32% | Health Technology | Strong buy |
 ZEGASTRAZENECA PLC | 222.71 B CHF | 142.148 CHF | +0.35% | 4 | 0.14 | 38.71 | 3.67 CHF | +28.81% | 1.85% | Health Technology | Buy |
 ROGROCHE GS | 186.669 B CHF | 228.8 CHF | −0.48% | 1.047 M | 0.70 | 16.00 | 14.30 CHF | −11.70% | 4.18% | Health Technology | Neutral |
| RHO5ROCHE HLDGS AG | 186.669 B CHF | 229.135 CHF | −0.68% | 26 | 0.29 | 16.02 | 14.30 CHF | −11.70% | 4.18% | Health Technology | Neutral |
| ROROCHE I | 186.669 B CHF | 252.0 CHF | −1.10% | 51.9 K | 1.32 | 17.62 | 14.30 CHF | −11.70% | 3.77% | Health Technology | Neutral |
| RHOROCHE HLDGS AG | 186.669 B CHF | 247.058 CHF | +2.62% | 333 | 7.47 | 17.28 | 14.30 CHF | −11.70% | 3.77% | Health Technology | Neutral |
 NOVNEENOVARTIS N 2. LINIE | 182.285 B CHF | 91.27 CHF | −1.01% | 250 K | 1.00 | 13.98 | 6.53 CHF | +110.97% | 3.59% | Health Technology | — |
| NOTNOVARTIS AG | 182.285 B CHF | 91.120 CHF | −0.75% | 38 | 0.60 | 13.95 | 6.53 CHF | +110.97% | 3.59% | Health Technology | Neutral |
| NOVNNOVARTIS N | 182.285 B CHF | 91.11 CHF | −1.00% | 2.322 M | 0.84 | 13.95 | 6.53 CHF | +110.97% | 3.59% | Health Technology | Neutral |
 AMGAMGEN INC | 150.13 B CHF | 287.771 CHF | +1.79% | 1 | 0.06 | 45.62 | 6.31 CHF | −53.17% | 2.83% | Health Technology | Buy |
 PFEPFIZER INC | 149.753 B CHF | 26.379 CHF | −0.74% | 390 | 0.65 | — | −0.05 CHF | −101.18% | 5.71% | Health Technology | Buy |
 VX1VERTEX PHARMACEUTICALS INC | 107.903 B CHF | 415.325 CHF | +14.38% | 1 | 0.08 | 29.87 | 13.91 CHF | +21.00% | 0.00% | Health Technology | Buy |
 RGOREGENERON PHARMACEUTICALS INC | 99.301 B CHF | 904.147 CHF | +10.50% | 35 | 4.67 | 29.61 | 30.54 CHF | −9.39% | 0.00% | Health Technology | Buy |
 GS71GSK PLC | 84.548 B CHF | 20.486 CHF | −1.47% | 10 | 0.06 | 16.47 | 1.24 CHF | −68.16% | 3.27% | Health Technology | Buy |
 BRMBRISTOL-MYRS SQUIB | 76.498 B CHF | 37.962 CHF | −6.49% | 100 | 0.50 | — | −2.80 CHF | −189.04% | 5.67% | Health Technology | Neutral |
 MRKMERCK KGAA | 72.299 B CHF | 163.237 CHF | +11.03% | 50 | 0.44 | 26.78 | 6.10 CHF | −17.58% | 1.31% | Health Technology | Strong buy |
 LONNLONZA N | 38.092 B CHF | 495.2 CHF | −3.43% | 262.252 K | 1.31 | 55.79 | 8.88 CHF | −77.54% | 0.68% | Health Technology | Strong buy |
| LO3LONZA GROUP AG | 38.092 B CHF | 498.313 CHF | −2.25% | 13 | 2.32 | 56.14 | 8.88 CHF | −77.54% | 0.68% | Health Technology | Strong buy |
| LONNELONZA N 2. LINIE | 38.092 B CHF | 495.4 CHF | −3.58% | 4 K | 0.88 | 55.81 | 8.88 CHF | −77.54% | 0.68% | Health Technology | — |
 BAYNBAYER AG | 27.589 B CHF | 27.359 CHF | −2.29% | 7 | 0.01 | — | −3.09 CHF | −200.75% | 0.39% | Health Technology | Neutral |
 UNCUCB | 24.082 B CHF | 128.001 CHF | +7.50% | 20 | 0.31 | 78.38 | 1.63 CHF | −71.10% | 0.74% | Health Technology | Buy |
 SDZSANDOZ GROUP N | 14.012 B CHF | 32.29 CHF | −0.68% | 595.126 K | 0.69 | — | — | — | 0.00% | Health Technology | Buy |
| D8YSANDOZ GROUP AG | 14.012 B CHF | 32.300 CHF | −0.47% | 232 | 2.99 | — | — | — | 0.00% | Health Technology | Buy |
 BANBBACHEM HOLDING AG | 6.476 B CHF | 89.535 CHF | +9.91% | 120 | 0.53 | 59.99 | 1.49 CHF | −7.80% | 0.93% | Health Technology | Neutral |
| BANBBACHEM N | 6.476 B CHF | 84.70 CHF | −1.91% | 55.959 K | 0.81 | 56.75 | 1.49 CHF | −7.80% | 0.93% | Health Technology | Neutral |
 SFZNSIEGFRIED N | 3.803 B CHF | 879 CHF | −0.79% | 3.935 K | 0.77 | 33.52 | 26.22 CHF | +19.06% | 0.38% | Health Technology | Buy |
| SQGSIEGFRIED HLDG AG | 3.803 B CHF | 880.644 CHF | +0.13% | 3 | 0.28 | 33.58 | 26.22 CHF | +19.06% | 0.38% | Health Technology | Buy |
 EVTEVOTEC SE | 1.617 B CHF | 9.335 CHF | −9.45% | 133 | 0.17 | — | −0.50 CHF | −182.96% | 0.00% | Health Technology | Strong buy |
 41XARDELYX INC | 1.445 B CHF | 7.357 CHF | −9.92% | 500 | 0.33 | — | −0.26 CHF | +28.58% | 0.00% | Health Technology | Strong buy |
 COPNCOSMO PHARM N | 1.216 B CHF | 71.2 CHF | −1.39% | 12.392 K | 0.82 | 860.94 | 0.08 CHF | −93.91% | 1.42% | Health Technology | Strong buy |
| C43COSMO PHARMA N.V. | 1.216 B CHF | 73.409 CHF | +2.47% | 150 | 0.17 | 887.65 | 0.08 CHF | −93.91% | 1.42% | Health Technology | Strong buy |
 FYBFORMYCON AG | 772.626 M CHF | 43.735 CHF | −1.85% | 200 | 1.22 | 9.96 | 4.39 CHF | — | 0.00% | Health Technology | Strong buy |
 5CVCUREVAC NV | 756.324 M CHF | 3.353 CHF | −4.28% | 70 | 0.04 | — | −1.19 CHF | +15.68% | 0.00% | Health Technology | Buy |
 BSLNBASILEA N | 533.008 M CHF | 43.45 CHF | −1.92% | 30.178 K | 1.05 | 82.26 | 0.53 CHF | — | 0.00% | Health Technology | Buy |
 IDIAIDORSIA N | 430.845 M CHF | 2.250 CHF | −1.32% | 412.87 K | 0.82 | — | −0.59 CHF | +87.58% | 0.00% | Health Technology | Sell |
| 19TIDORSIA LTD | 430.845 M CHF | 2.256 CHF | +14.69% | 200 | 0.02 | — | −0.59 CHF | +87.58% | 0.00% | Health Technology | Sell |
 0ETESPERION THERAPEUT | 332.162 M CHF | 2.009 CHF | −7.63% | 2.5 K | — | — | −0.91 CHF | +70.90% | 0.00% | Health Technology | Buy |
 ER4EMERGENT BIOSOLUTI | 228.249 M CHF | 4.346 CHF | +128.86% | 1.5 K | 5.43 | — | −9.94 CHF | −34.83% | 0.00% | Health Technology | Neutral |
 NWRNNEWRON PHARMA N | 180.915 M CHF | 9.60 CHF | −1.13% | 44.626 K | 0.44 | — | −0.88 CHF | +2.62% | 0.00% | Health Technology | Strong buy |
 SANNSANTHERA N | 81.505 M CHF | 9.52 CHF | +2.48% | 10.184 K | 0.84 | — | — | — | 0.00% | Health Technology | Buy |
 CURNCURATIS HOLDING AG | 30.165 M CHF | 6.500 CHF | −5.52% | 7.887 K | 1.10 | — | −170.60 CHF | −4277.01% | 0.00% | Health Technology | — |
 RLFRELIEF THERAPEUTICS N | 15.273 M CHF | 1.255 CHF | +0.40% | 7.564 K | 0.79 | — | −8.42 CHF | −377.09% | 0.00% | Health Technology | — |
 ADXNADDEX N | 13.421 M CHF | 0.0676 CHF | −7.14% | 522.245 K | 1.71 | — | −0.14 CHF | +71.60% | 0.00% | Health Technology | Strong sell |
 SPEXSPEXIS N | 4.574 M CHF | 0.0600 CHF | −11.24% | 342.992 K | 2.79 | — | — | — | 0.00% | Health Technology | — |
| GGALDGALDERMA GROUP N | — | 72.90 CHF | −1.82% | 185.572 K | 0.97 | — | — | — | — | Health Technology | Buy |